| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |